Related Experiment Video
Updated: Mar 19, 2026
14:57
Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
15.3K
Structure- and isoform-specific glucuronidation of six curcumin analogs
Summary
Researchers studied glucuronidation of six galangal-derived curcumin analogs using human liver microsomes and UGT enzymes. Results show structure-specific glucuronidation, aiding development of improved curcumin analogs with better metabolic properties.
Area of Science:
- Pharmacology
- Drug Metabolism
- Medicinal Chemistry
Background:
- Curcumin analogs derived from galangal are potential therapeutic agents.
- Understanding their metabolic pathways, particularly glucuronidation, is crucial for drug development.
- Glucuronidation, mediated by UDP-glucuronosyltransferases (UGTs), significantly impacts drug efficacy and clearance.
Purpose of the Study:
- To characterize the glucuronidation of six novel curcumin analogs (RAO-3, RAO-8, RAO-9, RAO-18, RAO-19, RAO-23) using human liver microsomes (HLM) and expressed UGT enzymes.
- To elucidate the structure-activity relationships governing the glucuronidation of these analogs.
- To identify specific UGT isoforms involved in the metabolism of these compounds.
Main Methods:
- Incubation of curcumin analogs with HLM and twelve recombinant UGT enzymes.
- Identification and characterization of glucuronide metabolites using high-resolution mass spectrometry.
- Analysis of fragmentation patterns to distinguish between alcoholic and phenolic glucuronides.
- Enzyme kinetics and isoform mapping studies.
Main Results:
- Single glucuronide metabolites were formed from each analog, confirmed by mass spectrometry.
- Five of the six analogs (excluding RAO-23) underwent significant glucuronidation.
- The presence of a methoxy group generally increased glucuronidation liability.
- UGT1A9 and UGT2B7 were key for alcoholic analogs (RAO-3, RAO-18).
- UGT1A9, UGT2B4, UGT2B7, UGT2B15, and UGT2B17 were important for phenolic analogs (RAO-8, RAO-9, RAO-19).
- Aliphatic chain conjugation was critical for gastrointestinal UGT selectivity (UGT1A7, 1A8, 1A10).
Conclusions:
- Glucuronidation of galangal-derived curcumin analogs is highly structure- and UGT isoform-specific.
- Metabolic profiles vary based on the analog's chemical structure, particularly hydroxyl and methoxy group positions.
- This detailed understanding of glucuronidation pathways can guide the rational design of curcumin analogs with optimized pharmacokinetic properties.
Related Concept Videos
01:24Phase II Reactions: Glucuronidation
2.0K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
2.0K
01:14Drug Metabolism: Phase II Reactions
5.5K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.5K
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
57
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
57
01:19Phase II Reactions: Sulfation and Conjugation with α-Amino Acids
1.2K
Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme...
1.2K
01:22Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
1.2K
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
1.2K
01:14Phase II Conjugation Reactions: Overview
1.1K
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
1.1K